Befejeződött1. fázis
Intermittent ibrutinib in chronic lymphocytic leukemia
Key facts
- Where
- Falun, Gavle, Gothenburg, Lund, Orebro, Solna, Umeå és Uppsala, SvédországSee the 8 sites
- Phase
- 1. fázis
Where in Svédország
- Region DalarnaFalun, SvédországNo longer taking part
- Region GaevleborgGavle, SvédországNo longer taking part
- Sahlgrenska University Hospital-Vastra GotalandsregionenGothenburg, SvédországNo longer taking part
- Lund University HospitalLund, SvédországNo longer taking part
- Region Oerebro LaenOrebro, SvédországNo longer taking part
- Karolinska University HospitalSolna, SvédországNo longer taking part
- Norrlands University HospitalUmeå, SvédországNo longer taking part
- Uppsala University HospitalUppsala, SvédországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Karolinska University Hospital
- Trial code
- EU 2023-508638-32-00
- Record updated
- 2023. november 10.